Yoshitaka Honma
Department Of Head And Neck
Japan
Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 157 publications
A multicenter randomized phase III trial to evaluate the value of omission of elective neck dissection for T3-T4aN0 laryngeal cancer: JCOG2407 (JALNECK).
Journal: Japanese journal of clinical oncology
Published: May 17, 2026
HER2 Intratumoral Heterogeneity in Salivary Duct Carcinoma: Association With Treatment Response and Comparison Between Primary and Metastatic Lesions.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: May 05, 2026
Biomarker-Driven Initial Systemic Therapy Enabling Curative-Intent Treatment in Non-Metastatic Unresectable Salivary Duct Carcinoma: A Multi-Institutional Retrospective Study.
Journal: Head & neck
Published: March 28, 2026
A multicenter randomized phase III trial of weekly cisplatin chemoradiotherapy versus radiotherapy in elderly patients with head and neck squamous cell carcinoma unfit for high-dose cisplatin: JCOG2405 (ELDER-WEEKLY).
Journal: Japanese journal of clinical oncology
Published: March 07, 2026
Prognostic factors for overall survival in advanced digestive neuroendocrine carcinoma treated with first-line cisplatin-based chemotherapy: a post hoc analysis of JCOG1213.
Journal: ESMO gastrointestinal oncology
Published: February 06, 2026
Non-surgical definitive treatment and geriatric assessment in older patients with locally advanced head and neck cancer.
Journal: Japanese journal of clinical oncology
Published: January 31, 2026
Enfortumab Vedotin plus Pembrolizumab as First-line Treatment in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Results from EV-202 Cohort 9.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 24, 2025
FOLFOX plus nivolumab combination therapy for cisplatin-unfit patients with untreated advanced esophageal squamous cell carcinoma.
Journal: Esophagus : official journal of the Japan Esophageal Society
Published: December 20, 2025
Impact of Neoadjuvant Docetaxel, Cisplatin, and 5-Fluorouracil Therapy on Synchronous Early-Stage Oropharyngeal/Hypopharyngeal Cancer in Patients With Esophageal Cancer.
Journal: Head & neck
Published: November 04, 2025
History of Head and Neck Cancer as a Predictor of Recurrence and Second Primary Tumors After Transoral Videolaryngoscopic Surgery in Patients With Hypopharyngeal Squamous Cell Carcinoma.
Journal: Head & neck
Published: October 11, 2025
Last Updated: 09/26/2026